STRS Ohio’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

STRS Ohio’s Portfolio PSTX Stock Details PSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-67,300	Closed	-$646K	–	2058
2024 Q4	$646K	Sell	67,300 -57,000	-46%	-$297K	﹤0.01%	1029
2024 Q3	$355K	Hold	124,300	–	–	﹤0.01%	1397
2024 Q2	$363K	Buy	124,300 +12,700	+11%	+$34.7K	﹤0.01%	1377
2024 Q1	$356K	Buy	111,600 +91,500	+455%	+$305K	﹤0.01%	1380
2023 Q4	$67K	Hold	20,100	–	–	﹤0.01%	1744
2023 Q3	$47K	Buy	+20,100	New	+$42.1K	﹤0.01%	1799
2021 Q2	–	Sell	-3,400	Closed	-$32K	–	2460
2021 Q1	$32K	Hold	3,400	–	–	﹤0.01%	2079
2020 Q4	$37K	Hold	3,400	–	–	﹤0.01%	2025
2020 Q3	$30K	Buy	+3,400	New	+$38.7K	﹤0.01%	2042

Other funds holding PSTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

STRS Ohio's PSTX Position: Q1 2025 in Review

STRS Ohio sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2025, closing a stake of 67,300 shares — an estimated $646K sold.

STRS Ohio first reported a position in PSTX in Q3 2020 and held it in 9 quarters. The position peaked at $646K in Q4 2024. 1 fund tracked by Wall St. Rank holds PSTX as of Q1 2025.

STRS Ohio reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
STRS Ohio sold 67,300 Poseida Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $646K.
STRS Ohio first reported a position in Poseida Therapeutics, Inc. Common Stock in Q3 2020 and held it in 9 quarters.
STRS Ohio's Poseida Therapeutics, Inc. Common Stock position peaked at $646K in Q4 2024.
1 fund tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2025.

Based on STRS Ohio's 13F filing for Q1 2025, filed 28 May 2025.